Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 30.72B |
| Enterprise value | 36.59B |
| Trailing P/E | 26.38 |
| Forward P/E | 13.91 |
| PEG ratio (5-yr expected) | 6.24 |
| Price/sales (ttm) | 3.18 |
| Price/book (mrq) | 2.02 |
| Enterprise value/revenue | 3.79 |
| Enterprise value/EBITDA | 17.37 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.04 |
| 52-week change 3 | -21.84% |
| S&P500 52-week change 3 | 18.96% |
| 52-week high 3 | 278.95 |
| 52-week low 3 | 189.44 |
| 50-day moving average 3 | 226.89 |
| 200-day moving average 3 | 231.06 |
Share statistics
| Avg vol (3-month) 3 | 1.04M |
| Avg vol (10-day) 3 | 1.09M |
| Shares outstanding 5 | 145.6M |
| Implied shares outstanding 6 | 145.6M |
| Float 8 | 145.09M |
| % held by insiders 1 | 0.16% |
| % held by institutions 1 | 92.95% |
| Shares short (15 Jul 2024) 4 | 3.63M |
| Short ratio (15 Jul 2024) 4 | 3.58 |
| Short % of float (15 Jul 2024) 4 | 2.81% |
| Short % of shares outstanding (15 Jul 2024) 4 | 2.49% |
| Shares short (prior month 14 Jun 2024) 4 | 3.07M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 3:1 |
| Last split date 3 | 18 Jan 2001 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 12.07% |
| Operating margin (ttm) | 27.28% |
Management effectiveness
| Return on assets (ttm) | 4.86% |
| Return on equity (ttm) | 8.05% |
Income statement
| Revenue (ttm) | 9.66B |
| Revenue per share (ttm) | 66.69 |
| Quarterly revenue growth (yoy) | -7.00% |
| Gross profit (ttm) | N/A |
| EBITDA | 2.52B |
| Net income avi to common (ttm) | 1.17B |
| Diluted EPS (ttm) | 8.00 |
| Quarterly earnings growth (yoy) | 1.40% |
Balance sheet
| Total cash (mrq) | 1.07B |
| Total cash per share (mrq) | 7.38 |
| Total debt (mrq) | 6.95B |
| Total debt/equity (mrq) | 45.66% |
| Current ratio (mrq) | 2.10 |
| Book value per share (mrq) | 104.49 |
Cash flow statement
| Operating cash flow (ttm) | 1.65B |
| Levered free cash flow (ttm) | 899.92M |
© 2024 Yahoo. All rights reserved.